This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Theralogics, Inc.. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Innovations by Denis C Guttridge
Introduction
Denis C Guttridge is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of medical treatments, particularly in addressing muscular wasting diseases. With a total of 2 patents, his work focuses on innovative methods that aim to improve the quality of life for individuals suffering from these conditions.
Latest Patents
Guttridge's latest patents include groundbreaking methods for treating muscular wasting diseases using NF-κB activation inhibitors. These methods specifically target conditions such as Duchenne muscular dystrophy. The innovative approach involves administering an NF-κB activation inhibitor capable of blocking the activation of NF-κB, which plays a crucial role in the progression of muscular wasting diseases.
Career Highlights
Throughout his career, Denis C Guttridge has been associated with Theralogics, Inc., where he has been able to apply his expertise in developing effective treatment methods. His dedication to research and innovation has positioned him as a key figure in the medical community, particularly in the realm of muscular dystrophy research.
Collaborations
One of his notable coworkers is Albert S Baldwin, with whom he has likely collaborated on various projects aimed at advancing treatment options for muscular wasting diseases.
Conclusion
Denis C Guttridge's contributions to the field of medical innovation are commendable. His work in developing methods for treating muscular wasting diseases showcases his commitment to improving patient outcomes. Through his patents and collaborations, he continues to make a significant impact in the medical research community.